Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy

Mohamed K. Diab, Asmaa S. A. Yassen, Sherif Ashraf Fahmy, Heba F. Ashour, Mohamed S. Nafie

Open source

DOI: 10.1039/d6md00450d
Published: 2026
Container: RSC Medicinal Chemistry
Publisher: Royal Society of Chemistry (RSC)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6md00450d,
  title = {Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy},
  author = {Mohamed K. Diab and Asmaa S. A. Yassen and Sherif Ashraf Fahmy and Heba F. Ashour and Mohamed S. Nafie},
  year = {2026},
  journal = {RSC Medicinal Chemistry},
  doi = {10.1039/d6md00450d},
  url = {https://doi.org/10.1039/d6md00450d}
}

RIS

TY  - JOUR
TI  - Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy
AU  - Mohamed K. Diab
AU  - Asmaa S. A. Yassen
AU  - Sherif Ashraf Fahmy
AU  - Heba F. Ashour
AU  - Mohamed S. Nafie
PY  - 2026
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00450d
UR  - https://doi.org/10.1039/d6md00450d
ER  -

APA

Diab, M. K., Yassen, A. S. A., Fahmy, S. A., Ashour, H. F., & Nafie, M. S. (2026). Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00450d

Source records

crossref · retrieved 2026-09-26T02:09:13.536Z